US OptionsDetailed Quotes
RIGL241220P5000
- 0.03
- 0.000.00%
15min DelayTrading Dec 11 12:15 ET
0.00High0.00Low
0.00Open0.03Pre Close0 Volume4 Open Interest5.00Strike Price0.00Turnover582.60%IV74.26%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0064Delta0.0015Gamma643.67Leverage Ratio-0.0200Theta0.0000Rho-4.09Eff Leverage0.0004Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet